drugset / Trial / NCT01266161

Multiple Dose Dental Pain Study Of Ibuprofen Extended Release

NCT01266161

Phase 3 Completed 106 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

The study hypothesis is that single and multiple doses of ibuprofen 600 mg ER caplets provide analgesic efficacy superior to placebo over 12-hour dosing intervals.

Timeline

Start
2010-11-22
Primary completion
2011-03-31
Completion
2011-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 600 mg

Indications

No indication recorded.